Browse verified doctors or let our care team help you find the doctor best suited to your condition, treatment goals, and budget.
At Burjeel Hospital, Abu Dhabi, patients can access Autologous Chondrocyte Implantation (ACI) through specialised cartilage restoration facilities staffed by experienced orthopaedic specialists. Established in 2012, the JCI hospital is located in Abu Dhabi, United Arab Emirates, and has 209 beds.
ACI uses the patient's own cartilage cells to help repair a localised cartilage defect. The treatment generally involves two stages: harvesting healthy chondrocytes and expanding them in a laboratory, followed by implantation into the damaged area. Imaging and clinical assessment help determine whether the patient is suitable for this treatment.
At American Oncology Institute, patients can access Autologous Chondrocyte Implantation (ACI) through specialised cartilage restoration facilities staffed by experienced orthopaedic specialists. Established in 2013, the NABH hospital is located in Hyderabad, India, and has 150 beds.
ACI uses the patient's own cartilage cells to help repair a localised cartilage defect. The treatment generally involves two stages: harvesting healthy chondrocytes and expanding them in a laboratory, followed by implantation into the damaged area. Imaging and clinical assessment help determine whether the patient is suitable for this treatment.
VM Medical Park Bursa Hospital offers specialised Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration technology and established orthopaedic treatment protocols. Established in 2017, the JCI hospital is situated in Bursa, Turkey, with 270 beds, serving local and international patients.
ACI is designed to support the repair of damaged joint cartilage using the patient's own cartilage cells. Treatment typically involves harvesting cells during an initial procedure, expanding them in the laboratory, and implanting them into the cartilage defect during a subsequent procedure. Before treatment, the orthopaedic team evaluates the patient's symptoms, cartilage defect, joint condition, imaging results, and suitability for cell-based cartilage restoration.
Medical Park Goztepe Hospital offers advanced Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration techniques and internationally accepted treatment protocols. Established in 2005, the JCI hospital is located in Istanbul, Turkey, with 293 beds and provides specialised orthopaedic care for local and international patients.
ACI is a cartilage restoration procedure used to treat selected focal cartilage defects, particularly in the knee. Healthy cartilage cells are collected from the patient's joint, expanded in a laboratory, and later implanted into the damaged area. The orthopaedic specialist evaluates the size and location of the cartilage defect, joint stability, and overall knee health before treatment.
At Baskent University Istanbul Hospital, patients can access Autologous Chondrocyte Implantation (ACI) through specialised cartilage restoration facilities staffed by experienced orthopaedic specialists. Established in 1993, the JCI, ISO hospital is located in Istanbul, Turkey, and has 144 beds.
ACI uses the patient's own cartilage cells to help repair a localised cartilage defect. The treatment generally involves two stages: harvesting healthy chondrocytes and expanding them in a laboratory, followed by implantation into the damaged area. Imaging and clinical assessment help determine whether the patient is suitable for this treatment.
Meliva Kardiolita Hospital, Vilnius offers specialised Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration technology and established orthopaedic treatment protocols. Established in 1998, the JCI hospital is situated in Vilnius, Lithuania, with 36 beds, serving local and international patients.
ACI is designed to support the repair of damaged joint cartilage using the patient's own cartilage cells. Treatment typically involves harvesting cells during an initial procedure, expanding them in the laboratory, and implanting them into the cartilage defect during a subsequent procedure. Before treatment, the orthopaedic team evaluates the patient's symptoms, cartilage defect, joint condition, imaging results, and suitability for cell-based cartilage restoration.
At Circle Reading Hospital, patients can access Autologous Chondrocyte Implantation (ACI) through specialised cartilage restoration facilities staffed by experienced orthopaedic specialists. Established in 2012, the hospital is located in Reading, United Kingdom, and it has adequate bed capacity.
ACI uses the patient's own cartilage cells to help repair a localised cartilage defect. The treatment generally involves two stages: harvesting healthy chondrocytes and expanding them in a laboratory, followed by implantation into the damaged area. Imaging and clinical assessment help determine whether the patient is suitable for this treatment.
At Sanar International Hospital, patients can access Autologous Chondrocyte Implantation (ACI) through specialised cartilage restoration facilities staffed by experienced orthopaedic specialists. Established in 2018, the NABH, JCI, AACI hospital is located in Gurugram, India, and has 150 beds.
ACI uses the patient's own cartilage cells to help repair a localised cartilage defect. The treatment generally involves two stages: harvesting healthy chondrocytes and expanding them in a laboratory, followed by implantation into the damaged area. Imaging and clinical assessment help determine whether the patient is suitable for this treatment.
Chennai, India
At The Madras Institute of Orthopedics and Traumatology, patients can access Autologous Chondrocyte Implantation (ACI) through specialised cartilage restoration facilities staffed by experienced orthopaedic specialists. Established in 1999, the JCI, NABH hospital is located in Chennai, India, and has 1000 beds.
ACI uses the patient's own cartilage cells to help repair a localised cartilage defect. The treatment generally involves two stages: harvesting healthy chondrocytes and expanding them in a laboratory, followed by implantation into the damaged area. Imaging and clinical assessment help determine whether the patient is suitable for this treatment.
Quttainah Specialized Hospital offers specialised Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration technology and established orthopaedic treatment protocols. Established in 2020, the JCI hospital is situated in Dubai, United Arab Emirates, with beds, serving local and international patients.
ACI is designed to support the repair of damaged joint cartilage using the patient's own cartilage cells. Treatment typically involves harvesting cells during an initial procedure, expanding them in the laboratory, and implanting them into the cartilage defect during a subsequent procedure. Before treatment, the orthopaedic team evaluates the patient's symptoms, cartilage defect, joint condition, imaging results, and suitability for cell-based cartilage restoration.
Vinmec Hai Phong offers specialised Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration technology and established orthopaedic treatment protocols. Established in 2018, the JCI hospital is situated in Ha noi, Vietnam, with 200 beds, serving local and international patients.
ACI is designed to support the repair of damaged joint cartilage using the patient's own cartilage cells. Treatment typically involves harvesting cells during an initial procedure, expanding them in the laboratory, and implanting them into the cartilage defect during a subsequent procedure. Before treatment, the orthopaedic team evaluates the patient's symptoms, cartilage defect, joint condition, imaging results, and suitability for cell-based cartilage restoration.
With advanced orthopaedic and cartilage-care infrastructure, Manipal Hospital, Ghaziabad offers Autologous Chondrocyte Implantation (ACI) for eligible patients with specific cartilage injuries. Established in 2010, the NABH, NABL hospital is located in Ghaziabad, India, and has 9500 beds.
ACI may be considered for symptomatic, localised cartilage defects when other treatments have not provided adequate relief. The patient's own cartilage cells are harvested, multiplied in a laboratory, and later implanted into the affected area. A detailed evaluation of the cartilage lesion and surrounding joint structures is performed before treatment.
Cure My Knee offers advanced Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration techniques and internationally accepted treatment protocols. Established in 2020, the JCI, NABH hospital is located in Delhi, India, with beds and provides specialised orthopaedic care for local and international patients.
ACI is a cartilage restoration procedure used to treat selected focal cartilage defects, particularly in the knee. Healthy cartilage cells are collected from the patient's joint, expanded in a laboratory, and later implanted into the damaged area. The orthopaedic specialist evaluates the size and location of the cartilage defect, joint stability, and overall knee health before treatment.
With advanced orthopaedic and cartilage-care infrastructure, Vinmec Ha Long Hospital offers Autologous Chondrocyte Implantation (ACI) for eligible patients with specific cartilage injuries. Established in 2018, the JCI hospital is located in Ha noi, Vietnam, and has 500 beds.
ACI may be considered for symptomatic, localised cartilage defects when other treatments have not provided adequate relief. The patient's own cartilage cells are harvested, multiplied in a laboratory, and later implanted into the affected area. A detailed evaluation of the cartilage lesion and surrounding joint structures is performed before treatment.
Vinmec Central Park International Hospital offers specialised Autologous Chondrocyte Implantation (ACI) using modern cartilage restoration technology and established orthopaedic treatment protocols. Established in 2015, the JCI hospital is situated in Ho Chi Minh, Vietnam, with 178 beds, serving local and international patients.
ACI is designed to support the repair of damaged joint cartilage using the patient's own cartilage cells. Treatment typically involves harvesting cells during an initial procedure, expanding them in the laboratory, and implanting them into the cartilage defect during a subsequent procedure. Before treatment, the orthopaedic team evaluates the patient's symptoms, cartilage defect, joint condition, imaging results, and suitability for cell-based cartilage restoration.
